Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Nuclear Antigen in North Carolina
Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in North Carolina
| Provider | Medicare | Services |
|---|---|---|
| Laboratory Corporation Of America... | $14.94 | 2.3K |
| Pathgroup Labs, Llc | $14.93 | 524 |
| Quest Diagnostics Clinical... | $14.98 | 88 |
| Mako Medical Laboratories, Llc | $14.81 | 73 |
| Andor Labs | $14.98 | 53 |
| Laboratory Corporation Of America... | $14.98 | 13 |
North Carolina Pricing in Context
In North Carolina, CPT code 86664 (Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Nuclear Antigen) carries an average Medicare payment of $14.93 — 0% below the national benchmark of $14.94. 12 providers across the state submitted claims for this procedure in 2023, performing 3.0K total services. Individual payments in NC ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in North Carolina is $90.61, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because North Carolina sits below the national Medicare average, commercial rates in the state may also run lower than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Immunology procedures, the estimated commercial insurance price in North Carolina lands near $32.54, with self-pay cash prices typically around $36.11. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Nuclear Antigen cost in North Carolina?
The average Medicare payment for Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Nuclear Antigen in North Carolina is $14.93, which is 0% below the national average of $14.94. Providers in NC typically bill $90.61 for this procedure.
What does Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Nuclear Antigen cost with insurance in North Carolina?
With commercial insurance in North Carolina, Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Nuclear Antigen costs an estimated $32.54. Without insurance, the estimated cash price is $36.11. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Nuclear Antigen in North Carolina?
12 providers in North Carolina billed Medicare for Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Nuclear Antigen in 2023, performing 3.0K total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Nuclear Antigen cheaper in North Carolina than the national average?
Yes — Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Nuclear Antigen costs 0% below the national average in North Carolina. The state average Medicare payment is $14.93 compared to $14.94 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.